ProShare Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
|
|||||
|
2025
Q1 | $187K | Sell |
|
|||||
|
2024
Q4 | $370K | Buy |
|
|||||
|
2024
Q3 | $659K | Buy |
|
|||||
|
2024
Q2 | $468K | Sell |
|
|||||
|
2024
Q1 | $512K | Buy |
|
|||||
|
2023
Q4 | $402K | Buy |
|
|||||
|
2023
Q3 | $283K | Sell |
|
|||||
|
2023
Q2 | $415K | Buy |
|
|||||
|
2023
Q1 | $399K | Sell |
|
|||||
|
2022
Q4 | $280K | Buy |
|
|||||
|
2022
Q3 | $338K | Buy |
|
|||||
|
2022
Q2 | $318K | Sell |
|
|||||
|
2022
Q1 | $654K | Sell |
|
|||||
|
2021
Q4 | $857K | Buy |
|
|||||
|
2021
Q3 | $924K | Sell |
|
|||||
|
2021
Q2 | $1.09M | Buy |
|
|||||
|
2021
Q1 | $964K | Buy |
|
|||||
|
2020
Q4 | $570K | Buy |
|
|||||
|
2020
Q3 | $288K | Sell |
|
|||||
|
2020
Q2 | $273K | Buy |
|
|||||
|
2020
Q1 | $243K | Sell |
|
|||||
|
2019
Q4 | $805K | Sell |
|
|||||
|
2019
Q3 | $904K | Sell |
|
|||||
|
2019
Q2 | $905K | Sell |
|
|||||
|
2019
Q1 | $1.24M | Buy |
|
|||||
|
2018
Q4 | $1.08M | Sell |
|
|||||
|
2018
Q3 | $1.9M | Sell |
|
|||||
|
2018
Q2 | $1.57M | Sell |
|
|||||
|
2018
Q1 | $1.32M | Sell |
|
|||||
|
2017
Q4 | $1.75M | Buy |
|
|||||
|
2017
Q3 | $1.66M | Buy |
|
|||||
|
2017
Q2 | $1.11M | Sell |
|
|||||
|
2017
Q1 | $905K | Sell |
|
|||||
|
2016
Q4 | $951K | Buy |
|
|||||
|
2016
Q3 | $1.07M | Sell |
|
|||||
|
2016
Q2 | $1.93M | Buy |
|
|||||
|
2016
Q1 | $2.35M | Sell |
|
|||||
|
2015
Q4 | $2.97M | Buy |
|
|||||
|
2015
Q3 | $2.31M | Sell |
|
|||||
|
2015
Q2 | $2.31M | Buy |
|
|||||
|
2015
Q1 | $2.16M | Buy |
|
|||||
|
2014
Q4 | $1.78M | Buy |
|
|||||
|
2014
Q3 | $1.55M | Sell |
|
|||||
|
2014
Q2 | $1.9M | Sell |
|
|||||
|
2014
Q1 | $2.01M | Buy |
|
|||||
|
2013
Q4 | $742K | Buy |
|
|||||
|
2013
Q3 | $719K | Buy |
|
|||||
|
2013
Q2 | $468K | Buy |
|